Commit To Buy SciClone Pharmaceuticals At $7.50, Earn 15.5% Annualized Using Options
November 11, 2014 at 11:41 AM EST
Investors eyeing a purchase of SciClone Pharmaceuticals, Inc. (SCLN) shares, but tentative about paying the going market price of $8.30/share, might benefit from considering selling puts among the alternative strategies at their disposal..